Endüstriler
Showing 31–40 ile ilgili 134 results
-
IOL (Intra-Ocular Lens) Replacement in Private Healthcare Institutions Market in Hong Kong
StratejiHelix'e göre, the IOL (intra-ocular lens) replacement in private healthcare institutions market in Hong Kong is expected to increase at a CAGR of 8.3% till 2027.
-
Laser-Assisted in situ Keratomileusis (LASIK) in Private Healthcare Institutions Market in Hong Kong
According to a statistic by StrategyHelix, the laser-assisted in situ keratomileusis (LASIK) in private healthcare institutions market in Hong Kong is set to fall at CAGR of -13.3% in the next five years.
-
Small Incision Lenticule Extraction (SMILE) in Private Healthcare Institutions Market in Hong Kong
The small incision lenticule extraction (SMILE) in private healthcare institutions market in Hong Kong is projected to expand by a CAGR of 19.6% itibaren 2021 başından sonuna kadar 2027, according to data and analytics company StrategyHelix.
-
Ophthalmic Healthcare Service Market in Hong Kong
A statistic by StrategyHelix indicates that the ophthalmic healthcare service market in Hong Kong is expected to increase by US$ 422 million from 2021 ile 2027, garnering a CAGR of 5.3% tahmin dönemi boyunca.
-
Quadrivalent Influenza Vaccine Market in China
The quadrivalent influenza vaccine market in China is set to increase by US$ 2,512 million from 2021 ile 2027, representing a compound annual growth rate (CAGR) ile ilgili 20.9% tahmin dönemi boyunca.
-
Shingles Vaccine Market in China
The shingles vaccine market in China is poised to grow by US$ 5,886 million from 2021 ile 2027, registering a CAGR of 49.2% tahmin dönemi boyunca, according to StrategyHelix.
-
HPV Vaccine Market in China
The HPV vaccine market in China is poised to grow by US$ 5,054 million from 2021 ile 2027, registering a CAGR of 18.7% tahmin dönemi boyunca, according to StrategyHelix.
-
Vaccine Market in China
StratejiHelix'e göre, the vaccine market in China is expected to increase by US$ 2,663 sırasında milyon 2021-2027, expanding at a CAGR of 7.7% tahmin dönemi boyunca.
-
Global PD-1 (PD-L1) Therapy Market
According to a statistic by StrategyHelix, the global PD-1 (PD-L1) therapy market is poised to grow at a CAGR of around 16.3% over the analysis period of 2021 ile 2027.
-
PD-1 (PD-L1) Therapy Market in China
The PD-1 (PD-L1) therapy market in China is poised to grow by US$ 4,330 sırasında milyon 2021-2027, CAGR'da ilerliyor 12.3% tahmin dönemi boyunca, according to data and analytics company StrategyHelix.